112 related articles for article (PubMed ID: 26400998)
1. Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C-Coinfected Persons.
Brunet L; Moodie EEM; Young J; Cox J; Hull M; Cooper C; Walmsley S; Martel-Laferrière V; Rachlis A; Klein MB; ; Cohen J; Conway B; Cooper C; Côté P; Cox J; Gill J; Haider S; Sadr A; Johnston L; Hull M; Montaner J; Moodie E; Pick N; Rachlis A; Rouleau D; Sandre R; Tyndall JM; Vachon ML; Sanche S; Skinner S; Wong D
Clin Infect Dis; 2016 Jan; 62(2):242-249. PubMed ID: 26400998
[TBL] [Abstract][Full Text] [Related]
2. Reproductive Aging and Hepatic Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women.
Sarkar M; Dodge JL; Greenblatt RM; Kuniholm MH; DeHovitz J; Plankey M; Kovacs A; French AL; Seaberg EC; Ofotokun I; Fischl M; Overton E; Kelly E; Bacchetti P; Peters MG;
Clin Infect Dis; 2017 Oct; 65(10):1695-1702. PubMed ID: 29020239
[TBL] [Abstract][Full Text] [Related]
3. Chronic hepatitis C virus infection and subsequent HIV viral load among women with HIV initiating antiretroviral therapy.
Willis SJ; Cole SR; Westreich D; Edmonds A; Hurt CB; Albrecht S; Anastos K; Augenbraun M; Fischl M; French AL; Kalapila AG; Karim R; Peters MG; Plankey M; Seaberg EC; Tien PC; Adimora AA
AIDS; 2018 Mar; 32(5):653-661. PubMed ID: 29334550
[TBL] [Abstract][Full Text] [Related]
4. Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection.
Lo Re V; Zeldow B; Kallan MJ; Tate JP; Carbonari DM; Hennessy S; Kostman JR; Lim JK; Goetz MB; Gross R; Justice AC; Roy JA
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1172-1181. PubMed ID: 28722244
[TBL] [Abstract][Full Text] [Related]
5. Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus.
French AL; Evans CT; Agniel DM; Cohen MH; Peters M; Landay AL; Desai SN
J Infect Dis; 2013 Aug; 208(4):679-89. PubMed ID: 23687224
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Assessment of the Enhanced Liver Fibrosis Score in the Era of Contemporary HIV and Hepatitis C Virus Treatment.
Gardner AR; Ma Y; Bacchetti P; Price JC; Kuniholm MH; French AL; Gange S; Adimora AA; Minkoff H; Kassaye S; Ofotokun I; Rosenberg W; Kovacs AAZ; Tien PC
J Infect Dis; 2023 May; 227(11):1274-1281. PubMed ID: 35951669
[TBL] [Abstract][Full Text] [Related]
7. A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection.
Moqueet N; Kanagaratham C; Gill MJ; Hull M; Walmsley S; Radzioch D; Saeed S; Platt RW; Klein MB;
PLoS One; 2017; 12(5):e0176282. PubMed ID: 28467457
[TBL] [Abstract][Full Text] [Related]
8. Steatotic liver disease progression in persons with HIV: weighting for answers.
Mauss S; Stapleton JT; Thomas DL
AIDS; 2024 Jul; 38(9):1432-1434. PubMed ID: 38932746
[No Abstract] [Full Text] [Related]
9. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.
Ma Q; Vaida F; Wong J; Sanders CA; Kao YT; Croteau D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; Morgello S; Simpson DM; Heaton RK; Grant I; Letendre SL;
J Neurovirol; 2016 Apr; 22(2):170-8. PubMed ID: 26407716
[TBL] [Abstract][Full Text] [Related]
10. Renal Toxicity of Concomitant Exposure to Tenofovir and Inhibitors of Tenofovir's Renal Efflux Transporters in Patients Infected With HIV Type 1.
Rokx C; Alshangi H; Verbon A; Zietse R; Hoorn EJ; Rijnders BJ
J Infect Dis; 2016 Feb; 213(4):561-8. PubMed ID: 26401025
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for vertical transmission of hepatitis C virus: a single center experience with 710 HCV-infected mothers.
Garcia-Tejedor A; Maiques-Montesinos V; Diago-Almela VJ; Pereda-Perez A; Alberola-Cuñat V; López-Hontangas JL; Perales-Puchalt A; Perales A
Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():173-7. PubMed ID: 26409061
[TBL] [Abstract][Full Text] [Related]
12. Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir.
Smith C; Weinberg A; Forster JE; Levin MJ; Davies J; Pappas J; Kinzie K; Barr E; Paul S; McFarland EJ
Infect Dis Obstet Gynecol; 2016; 2016():9848041. PubMed ID: 27127401
[TBL] [Abstract][Full Text] [Related]
13. In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana.
Powis KM; Smeaton L; Hughes MD; Tumbare EA; Souda S; Jao J; Wirth KE; Makhema J; Lockman S; Fawzi W; Essex M; Shapiro RL
AIDS; 2016 Jan; 30(2):211-20. PubMed ID: 26684818
[TBL] [Abstract][Full Text] [Related]
14. Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients.
Poizot-Martin I; Naqvi A; Obry-Roguet V; Valantin MA; Cuzin L; Billaud E; Cheret A; Rey D; Jacomet C; Duvivier C; Pugliese P; Pradat P; Cotte L;
PLoS One; 2015; 10(10):e0141164. PubMed ID: 26488159
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Acute Hepatitis C Infection with Pegylated Interferon and Ribavirin in Patients Coinfected with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis.
Zhang B; Nguyen NH; Yee BE; Yip B; Ayoub WS; Lutchman GA; Nguyen MH
Intervirology; 2015; 58(4):242-9. PubMed ID: 26402746
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial.
Rockstroh JK; Nelson M; Katlama C; Lalezari J; Mallolas J; Bloch M; Matthews GV; Saag MS; Zamor PJ; Orkin C; Gress J; Klopfer S; Shaughnessy M; Wahl J; Nguyen BY; Barr E; Platt HL; Robertson MN; Sulkowski M
Lancet HIV; 2015 Aug; 2(8):e319-27. PubMed ID: 26423374
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hepatitis C in patients with HIV.
Tang L; Kottilil S
Lancet HIV; 2015 Aug; 2(8):e308-9. PubMed ID: 26423368
[No Abstract] [Full Text] [Related]
18. The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.
Solomon MM; Schechter M; Liu AY; McMahan VM; Guanira JV; Hance RJ; Chariyalertsak S; Mayer KH; Grant RM;
J Acquir Immune Defic Syndr; 2016 Mar; 71(3):281-6. PubMed ID: 26413853
[TBL] [Abstract][Full Text] [Related]
19. The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy.
Koethe JR; Grome H; Jenkins CA; Kalams SA; Sterling TR
AIDS; 2016 Jan; 30(1):83-91. PubMed ID: 26418084
[TBL] [Abstract][Full Text] [Related]
20. Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.
Silverberg MJ; Lau B; Achenbach CJ; Jing Y; Althoff KN; D'Souza G; Engels EA; Hessol NA; Brooks JT; Burchell AN; Gill MJ; Goedert JJ; Hogg R; Horberg MA; Kirk GD; Kitahata MM; Korthuis PT; Mathews WC; Mayor A; Modur SP; Napravnik S; Novak RM; Patel P; Rachlis AR; Sterling TR; Willig JH; Justice AC; Moore RD; Dubrow R;
Ann Intern Med; 2015 Oct; 163(7):507-18. PubMed ID: 26436616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
